跳至主要内容
临床试验/NCT02244619
NCT02244619已完成4 期

Randomized, Double-Blind, Study Comparing Oral Acetaminophen Plus Intravenous (IV) Placebo to Oral Placebo Plus IV Acetaminophen Given Perioperatively for Controlling Pain in the 24hr Post-op Period After Total Hip or Knee Joint Replacement

Kettering Health Network1 个研究点 分布在 1 个国家目标入组 515 人开始时间: 2014年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
515
试验地点
1
主要终点
Total Post-operative Use of Opioids

研究概览

简要总结

The purpose of the study is to evaluate post-op pain requirements in patients undergoing hip or knee replacement surgery who perioperatively receive either Oral acetaminophen or IV acetaminophen

详细描述

Subjects will be randomized to receive perioperative dosing of either:

  1. Oral acetaminophen (Tylenol) 1000mg with IV Placebo (100ml Normal Saline), OR,
  2. IV acetaminophen (Ofirmev) 1000mg/100ml with Oral Placebo (oral capsules).

Subject pain levels and post-operative opioid use will be tracked for up to 24 hours after surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years of age and older
  • Able to provide written consent
  • Able to read and write in English
  • Weighing over 50 kg
  • Will undergo total hip or total knee joint replacement

排除标准

  • Non-verbal patients
  • Unable to use numeric pain scale
  • Allergic to the test article
  • Documented hepatic impairment or failure
  • Current illicit drug use
  • Requires traumatic or emergent surgery
  • Pregnant women
  • Women who are breastfeeding
  • Prisoners
  • Cognitively impaired requiring Legally Authorized Representative (LAR) or Power of Attorney (POA)
  • Unable to swallow oral capsules

研究组 & 干预措施

Oral acetaminophen

Active Comparator

Subjects receive 2 capsules each containing Tylenol 500 mg caplets. The test article administration will be initiated 60 minutes (± 15 minutes) prior to the scheduled surgery start time.

干预措施: Oral acetaminophen (Drug)

IV acetaminophen

Active Comparator

Subjects receive Ofirmev 1000 mg in 100 ml Normal Saline IV infusion. The test article will be given perioperatively at the discretion of the attending anesthesiologist.

干预措施: IV acetaminophen (Drug)

结局指标

主要结局

Total Post-operative Use of Opioids

时间窗: During post-op period up to 24 hrs after surgery

Post-operative use of opioids, measured in morphine milligram equivalent (MME) units

次要结局

  • Patient-rated Pain in the Post-operative Period(Standard-of-care post-op assessment intervals during post-op period up to 24 hrs after surgery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验